<2021年>

英文原著

●Kawakami I, Motoda A, Hashimoto M, Shimozawa A, Masuda-Suzukake M, Ohtani R, Takase M, Kumashiro M, Samejima K, Hasegawa M.

Progression of phosphorylated α-synuclein in Macaca fuscata. Brain Pathol. 22; e12952, 2021.

 

●Shiga Y, Aoki S, Hosomi N, Nomura R, Nakamori M, Nezu T, Tachiyama K, Kamimura T, Kinoshita N, Shimomura R, Hayashi Y, Matsushima H, Imamura E, Ueno H, Wakabayashi S, Nakano K, Kohriyama T, Maruyama H.

cnm-Positive Streptococcus mutans and diffusion-weighted imaging hyperintensities in acute intracerebral hemorrhage. Eur J Neurol. 28(5): 1581-1589, 2021.

 

●Toko M, Kitamura J, Ueno H, Ohshita T, Nemoto K, Ochi K, Higaki T, Akiyama Y, Awai K, Maruyama H.

Prospective Memory Deficits in Multiple Sclerosis: Voxel-based Morphometry and Double Inversion Recovery Analysis. Intern Med. 60(1): 39-46, 2021.

 

●Matsubara T, Izumi Y, Oda M, Takahashi M, Maruyama H, Miyamoto R, Watanabe C, Tachiyama Y, Morino H, Kawakami H, Saito Y, Murayama S.

An autopsy report of a familial amyotrophic lateral sclerosis case carrying VCP Arg487His mutation with a unique TDP43 proteinopathy. Neuropathology. 41(2): 118-126, 2021.

 

●Neshige S.

Psychiatric non-epileptic seizure: diagnostic utility of density spectral array. BMJ Case Rep. 14(1): e241015, 2021.

 

●Yamada H, Nishikawa T, Yamasaki M, Fukuba H, Ohmori H, Nakamura M, Miyachi T.

Deep vein thrombosis in patients with neuromusculardisease who undergo tracheotomy with positive pressureventilation. Neurol Clin Neurosci. 9: 63–67, 2021.

 

●Kanaya Y, Kume K, Morino H, Ohsawa R, Kurashige T, Kamada M, Torii T, Izumi Y, Maruyama H, Kawakami H.

Analysis of genetic risk factors in Japanese patients with Parkinson's disease. J Hum Genet. 66(10): 957-964, 2021.

 

●Neshige S, Ohshita T, Neshige R, Maruyama H.

Influence of current and previous smoking on current phenotype in Parkinson's disease. Journal of the Neurological Sciences. 427: 117534, 2021.

 

●Eto F, Koge J, Tanaka K, Yoshimoto T, Shiozawa M, Hatakeyama K, Toyoda K, Koga M.

Atherosclerotic Components in Thrombi Retrieved by Thrombectomy for Internal Carotid Artery Occlusion Due to Large Artery Atherosclerosis: A Case Report. Front Neurol. 12: 670610, 2021.

 

●Eto F, Yoshimoto T, Okazaki S, Nishimura K, Ogura S, Yamaguchi E, Fukuma K, Saito S, Washida K, Koga M, Toyoda k, Morimoto T, Maruyama H, Koizumi A, Ihara M.

RNF213 p.R4810K (c.14429G>A) variant determines anatomical variations of the circle of Willis in cerebrovascular disease. Front. Aging Neurosci. 13: 681743, 2021.

 

●Eto F, Washida K, Matsubara M, Makino H, Takahashi A, Noda K, Hattori Y, Nakaoku Y, Nishimura K, Hosoda K, Ihara M.

Glucose Fluctuation and Severe Internal Carotid Artery Siphon Stenosis in Type 2 Diabetes Patients. Nutrients. 13(7): 2379, 2021.

 

●Kikumoto M, Nezu T, Shiga Y, Motoda A, Toko M, Kurashige T, Ueno H, Takahashi T, Morino H, Sone J, Iwasaki Y, Sobue G, Maruyama H.

Case of Neuronal Intranuclear Inclusion Disease With Dynamic Perfusion Changes Lacking Typical Signs on Diffusion-Weighted Imaging. Neurol Genet. 7(4): e601, 2021.

 

●Takebayashi Y, Neshige S, Hayashi T, Aoki S, Ueno H, Iida K, Maruyama H.

A case of repetitive seizures following immune checkpoint inhibitor therapy as a feature of autoimmune encephalitis. Epileptic Disord. 23(5): 733-738, 2021.

 

●Eto F, Nagao Y, Kuramoto Y, Takagi T, Uchida K, Yoshimura S.

Mechanical Thrombectomy via the Transfemoral Approach for Acute Middle Cerebral Artery M1 Occlusion That Occurred during Intra-Aortic Balloon Pumping Application. Journal of Neuroendovascular Therapy. 15(3): 170–174, 2021.

 

●Neshige S, Hitomi T, Tojima M, Oi K, Kobayashi K, Matsuhashi M, Shimotake A, Matsumoto R, Kanda M, Maruyama H, Ishiura H, Tsuji S, Takahashi R, Ikeda A.

A Role of Aging in the Progression of Cortical Excitability in Benign Adult Familial Myoclonus Epilepsy type 1 Patients. Mov Disord. 36(10): 2446-2448, 2021.

 

●Neshige S, Ono N, Iryo T, Watanabe T, Yamada H, Mine N, Takebayashi Y, Kikumoto M, Toko M, Maruyama H,

Nationwide online EEG education during coronavirus disease 2019 pandemic. Clin Neurophysiol.  132(11): 2763-2765, 2021.

 

●Tojima M, Neshige S, Hitomi T, Matsuhashi M, Takahashi R, Ikeda A.

Marked response to perampanel: A decade-long course of giant somatosensory evoked potentials in Unverricht-Lundborg disease. Clinical Neurophysiology. 132(10): 2329-2331, 2021.

 

●COVIDSurg Collaborative (Neshige S), GlobalSurg Collaborative.

Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia. 76(6): 748-758, 2021.

 

●Neshige S, Iryo T, Ueno H, Maruyama H.

Extreme delta brush in anti-NMDAR encephalitis: Mimics and chameleons.  Epilepsia Open. 6(2): 443-446, 2021.

 

●Tojima M, Hitomi T, Matsuhashi M, Neshige S, Usami K, Oi K, Kobayashi K, Takeyama H, Shimotake A, Takahashi R, Ikeda A.

A Biomarker for Benign Adult Familial Myoclonus Epilepsy: High-Frequency Activities in Giant Somatosensory Evoked Potentials. Mov Disord. 36(10): 2335-2345, 2021.

 

●Neshige S, Ono N, Aoki S, Maruyama H.

Rapid ping-pong eye deviation following a recovery from carbon dioxide narcosis. BMJ Case Rep. 14(3): e241740, 2021.

 

●Neshige S, Yamada H, Maruyama H.

Emotional Facial Paresis in Temporal Lobe Epilepsy. Intern Med. 60(16): 2705-2706, 2021.
 

●Neshige S, Aoki S, Shishido T, Morino H, Iida K, Maruyama H.

Socio-economic impact on epilepsy outside of the nation-wide COVID-19 pandemic area. Epilepsy Behav. 117: 107886, 2021.

 

●Motoda A, Takahashi T, Watanabe C, Tachiyama Y, Ochi K, Saito Y, Iida A, Nishino I, Maruyama H.

An autopsied case of ADSSL1 myopathy. Neuromuscul Disord. 31(11): 1220-1225, 2021.

 

●Kurashige T, Takahashi T, Nagano Y, Sugie K, Maruyama H.

Krebs von den Lungen 6 decreased in the serum and muscle of GNE myopathy patients.

Neuropathology. 41(1): 29-36, 2021.

 

●Nishikawa Y, Watanabe K, Holobar A, Maeda N, Maruyama H, Tanaka S.

Identification of the laterality of motor unit behavior in female patients with parkinson's disease using high-density surface electromyography. Eur J Neurosci. 53(6): 1938-1949, 2021.

 

●Yamada H, Neshige S, Shishido T, Ueno H, Ohshita T, Morino H, Maruyama H.

Efficacy of Lacosamide in a Patient with Refractory Generalized Epilepsy Based on Video Electroencephalography. Intern Med. 60(22): 3621-3624, 2021.

 

●Toko M, Ohshita T, Kurashige T, Morino H, Kume K, Yamashita H, Sobue G, Iwasaki Y, Sone J, Kawakami H, Maruyama H.

FXTAS is difficult to differentiate from neuronal intranuclear inclusion disease through skin biopsy: a case report. BMC Neurol. 21(1): 396, 2021.

 

●Hara N, Nakamori M, Ayukawa T, Matsushima H, Hayashi Y, Imamura E, Mizoue T, Wakabayashi S.

Characteristics and Prognostic Factors of Swallowing Dysfunction in Patients with Lateral Medullary Infarction. J Stroke Cerebrovasc Dis. 30(12): 106122, 2021.

 

●Shiga Y, Nezu T, Nakamori M, Hosomi N, Akiyama Y, Tachiyama K, Kamimura T, Kinoshita N, Hayashi Y, Matsushima H, Imamura E, Aoki S, Ueno H, Ohshita T, Wakabayashi S, Yamasaki F, Awai K, Maruyama H.

Utility of Magnetic Resonance Spectroscopy for the Progression of Neurological Symptoms in Lenticulostriate Artery Territory Infarction. J Stroke Cerebrovasc Dis. 30(6):105747, 2021.

 

●Kuga J, Hironaka A, Ochi K, Sugimoto T, Nakamori M, Nezu T, Maruyama H.

Impact of anatomical variations on ultrasonographic reference values of lower extremity peripheral nerves. Muscle Nerve. 63(6): 890-896, 2021.

 

●Munenaga S, Usuda M, Ouhara K, Maetani Y, Kajiya M, Matsuda S, Furusho H, Miyauchi M, Nakamori M, Maruyama H, Nishi H, Kawaguchi H.

External cervical resorption detected via cone-beam computed tomography in a patient with myelin oligodendrocyte glycoprotein antibody-associated disease: A case report. Clin Case Rep. 9(7): e04415, 2021.

 

●Matias-Guiu JA, Sung SF, Hsieh CY, Nezu T, Porta-Etessam J, Allegri RF.

Editorial: Consequences of the COVID-19 Pandemic on Care for Neurological Conditions. Front Neurol. 12: 788912, 2021.

 

●Ohmori H, Kodama H, Takemoto M, Yamasaki M, Matsumoto T, Kumode M, Miyachi T, Sumimoto R.

Isolated neutropenia caused by copper deficiency due to jejunal feeding and excessive zinc intake: A case report. World J Clin Cases. 9(29): 8825-8830, 2021.

 

●Kurashige T.

Anti-HMGCR myopathy: clinical and histopathological features, and prognosis. Curr Opin Rheumatol. 33(6): 554-562, 2021.

 

●Matsubara T, Saito Y, Kurashige T, Higashihara M, Hasegawa F, Ogasawara M, Iida A, Nishino I, Adachi T, Kubota A, Murayama S.

Neuropathy/intranuclear inclusion bodies in oculopharyngodistal myopathy: A case report. eNeurologicalSci. 24: 100348, 2021.

 

●Kurashige T, Mito M, Yamamoto H, Sugiura T, Onoe T, Kuraoka K, Nakano K, Torii T.

Pembrolizumab-caused polyradiculoneuropathy as an immune-related adverse event. Neuropathology. 41(4): 266-272, 2021.

 

●Kumutpongpanich T, Ogasawara M, Ozaki A, Ishiura H, Tsuji S, Minami N, Hayashi S, Noguchi S, Iida A, Nishino I; OPDM_LRP12 Study Group, Mori-Yoshimura M, Oya Y, Ono K, Shimizu T, Kawata A, Shimohama S, Toyooka K, Endo K, Toru S, Sasaki O, Isahaya K, Takahashi MP, Iwasa K, Kira JI, Yamamoto T, Kawamoto M, Hamano T, Sugie K, Eura N, Shiota T, Koide M, Sekiya K, Kishi H, Hideyama T, Kawai S, Yanagimoto S, Sato H, Arahata H, Murayama S, Saito K, Hara H, Kanda T, Yaguchi H, Imai N, Kawagashira Y, Sanada M, Obara K, Kaido M, Furuta M, Kurashige T, Hara W, Kuzume D, Yamamoto M, Tsugawa J, Kishida H, Ishizuka N, Morimoto K, Tsuji Y, Tsuneyama A, Matsuno A, Sasaki R, Tamakoshi D, Abe E, Yamada S, Uzawa A.

Clinicopathologic Features of Oculopharyngodistal Myopathy With LRP12 CGG Repeat Expansions Compared With Other Oculopharyngodistal Myopathy Subtypes. JAMA Neurol. 78(7): 853-863, 2021.

 

●Imamura K, Yada Y, Izumi Y, Morita M, Kawata A, Arisato T, Nagahashi A, Enami T, Tsukita K, Kawakami H, Nakagawa M, Takahashi R, Inoue H.

Prediction Model of Amyotrophic Lateral Sclerosis by Deep Learning with Patient Induced Pluripotent Stem Cells. Ann Neurol. 89(6): 1226-1233, 2021.

 

●Kume K, Kamada M, Shimatani Y, Takata T, Izumi Y, Kawakami H.

Novel monoallelic variant in ERLIN2 causes spastic paraplegia converted to amyotrophic lateral sclerosis. J Neurol Sci. 430: 119984, 2021.

 

●Hirota S, Yasuda H, Kawakami H, Yoshinaga S.

Prospects and status of the dosimetry system for atomic bomb survivor cohort study conducted at Research Institute for Radiation Biology and Medicine of Hiroshima University. J Radiat Res. 62(Supplement_1): i107-i113, 2021.

 

●Naito H, Sugimoto T, Kimoto K, Abe T, Kawano T, Matsuoka C, Ohno N, Giga M, Kono T, Ueno H, Nomura E.

Clinical comorbidities correlated with a response to the cerebrospinal fluid tap test in idiopathic normal-pressure hydrocephalus. J Neurol Sci. 430: 120024, 2021.

 

●Kuroda N, Kubota T, Horinouchi T, Ikegaya N, Kitazawa Y, Kodama S, Matsubara T, Nagino N, Neshige S, Soga T, Sone D, Takayama Y, Kuramochi I, et al.

Risk factors for psychological distress in electroencephalography technicians during the COVID-19 pandemic: A national-level cross-sectional survey in Japan. Epilepsy & Behavior. 125: 108361, 2021.

 

●Tanei ZI, Saito Y, Ito S, Matsubara T, Motoda A, Yamazaki M, Sakashita Y, Kawakami I, Ikemura M, Tanaka S, Sengoku R, Arai T, Murayama S.

Lewy pathology of the esophagus correlates with the progression of Lewy body disease: a Japanese cohort study of autopsy cases. Acta Neuropathol. 141(1): 25-37, 2021.

 

●Kamimura T, Nakamori M, Imamura E, Hayashi Y, Matsushima H, Mizoue T, Wakabayashi S, Maruyama H.

Low-dose Contrast-induced Encephalopathy During Diagnostic Cerebral Angiography. Intern Med. 60(4): 629-63, 2021.

 

●Kurashige T, Kuramochi M, Ohsawa R, Yamashita Y, Shioi G, Morino H, Kamada M, Ayaki T, Ito H, Sotomaru Y, Maruyama H, Kawakami H.

Optineurin defects cause TDP43-pathology with autophagic vacuolar formation. Neurobiol Dis. 148: 105215, 2021.

 

●Ikawa F, Tanaka S, Harada K, Hide I, Maruyama H, Sakai N.

Detailed neuronal distribution of GPR3 and its co-expression with EF-hand calcium-binding proteins in the mouse central nervous system. Brain Res. 1750: 147166, 2021.

 

●Nakamori M, Hosomi N, Imamura E, Matsushima H, Maetani Y, Yoshida M, Yoshikawa M, Takeda C, Nagasaki T, Masuda S, Kayashita J, Tsuga K, Tanimoto K, Wakabayashi S, Maruyama H.

Association between stroke lesions and videofluoroscopic findings in acute stroke patients. J Neurol. 268(3): 1025-1035, 20201

 

●Kikumoto M, Aoki S, Shiga Y, Kinoshita N, Nezu T, Ueno H, Arihiro K, Maruyama H.

A Case of Giant Cell Arteritis with Internal Carotid Artery Occlusion in the Absence of Typical Clinical Features. Intern Med. 60(8): 1293-1297, 2021.

 

●Tachi K, Takata T, Kume K, Sone J, Kobara H, Deguchi K, Kawakami H, Masaki T.

Long-term MRI findings of adult-onset neuronal intranuclear inclusion disease. Clin Neurol Neurosurg. 201: 106456, 2021.

 

●Matsuoka T, Yamasaki M, Abe M, Matsuda Y, Morino H, Kawakami H, Sakimura K, Watanabe M, Hashimoto K.

Kv11 (ether-à-go-go-related gene) voltage-dependent K+ channels promote resonance and oscillation of subthreshold membrane potentials. J Physiol. 599(2): 547-569, 2021.

 

●Matsuoka T, Yamasaki M, Abe M, Matsuda Y, Morino H, Kawakami H, Sakimura K, Watanabe M, Hashimoto K.

Kv11 (ether-à-go-go-related gene) voltage-dependent K + channels promote resonance and oscillation of subthreshold membrane potentials. J Physiol. 599(2): 547-569, 2021.

 

●Nishikawa Y, Watanabe K, Takahashi T, Maeda N, Maruyama H, Kimura H.

The effect of electrical muscle stimulation on quadriceps muscle strength and activation patterns in healthy young adults. Eur J Sport Sci. 21(10): 1414-1422. 2021.

 

 

<2020年>

英文原著

●Tada Y, Kume K, Matsuda Y, Kurashige T, Kanaya Y, Ohsawa R, Morino H, Tabu H, Kaneko S, Suenaga T, Kakizuka A, Kawakami H.

Genetic screening for potassium channel mutations in Japanese autosomal dominant spinocerebellar ataxia. J Hum Genet. 65(4): 363-369, 2020.

 

●Matsuda Y, Morino H, Miyamoto R, Kurashige T, Kume K, Mizuno N, Kanaya Y, Tada Y, Ohsawa R, Yokota K, Shimozawa N, Maruyama H, Kawakami H.
Biallelic mutation of HSD17B4 induces middle age-onset spinocerebellar ataxia. Neurol Genet. 6(1): e396, 2020.

 

●Tahara M, Oeda T, Okada K, Kiriyama T, Ochi K, Maruyama H, Fukaura H, Nomura K, Shimizu Y, Mori M, Nakashima I, Misu T, Umemura A, Yamamoto K, Sawada H.
Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 19(4): 298-306, 2020.
 

●Ueno H, Kikumoto M, Takebayashi Y, Ishibashi H, Takahashi T, Yasutomi H, Umemoto K, Nakamichi K, Saijo M, Ichinohe T, Maruyama H.

Pomalidomide-associated progressive multifocal leukoencephalopathy in multiple myeloma: cortical susceptibility-weighted imaging hypointense findings prior to clinical deterioration. J Neurovirol. 26(3): 452-455, 2020.

 

●Godolphin PJ, Bath PM, Algra A, Berge E, Chalmers J, Eliasziw M, Hankey GJ, Hosomi N, Ranta A, Weimar C, Woodhouse LJ, Montgomery AA.

Cost-benefit of outcome adjudication in nine randomised stroke trials. Clin Trials. 17(5):576-580, 2020.
 

●Naito H, Hosomi N, Nezu T, Kuzume D, Aoki S, Morimoto Y, Yoshida T, Shiga Y, Kinoshita N, Ueno H, Maruyama H.

Prognostic role of the controlling nutritional status score in acute ischemic stroke among stroke subtypes. J Neurol Sci. 416: 116984, 2020.

 

●Naito H, Hosomi N, Kuzume D, Nezu T, Aoki S, Morimoto Y, Kinboshi M, Yoshida T, Shiga Y, Kinoshita N, Ueno H, Noma K, Maruyama H.

Increased blood pressure variability during the subacute phase in patients with ischemic stroke presenting with a low ankle-brachial index. Geriatr Gerontol Int. 20(5): 448-454, 2020.

 

●Toko M, Nezu T, Ueno H, Kamimura T, Aoki S, Hosomi N, Maruyama H.

A case of seronegative longitudinally extensive transverse myelitis with possible neuro sweet disease. eNeurologicalSci. 18: 100227, 2020.

 

●Kamimura T, Nezu T, Aoki S, Ueno H, Hosomi N, Maruyama H.

Conus Medullaris Infarction Involving the Paraspinal Muscles and Nerve Roots. J Stroke Cerebrovasc Dis. 29(8): 104983, 2020.

 

●Nezu T, Hosomi N, Kuzume D, Naito H, Aoki S, Morimoto Y, Kinboshi M, Shiga Y, Kinoshita N, Ueno H, Maruyama H.

Effects of vascular compression on the rostral ventrolateral medulla for blood pressure variability in stroke patients. J Hypertens. 38(12): 2443-2450, 2020.

 

●Kitamura J, Nagai M, Ueno H, Ohshita T, Kikumoto M, Toko M, Kato M, Dote K, Yamashita H, Kario K.

>The Insular Cortex, Alzheimer Disease Pathology, and Their Effects on Blood Pressure Variability. Alzheimer Dis Assoc Disord. 34(3): 282-291, 2020.

 

●Dodo Y, Takahashi T, Honjo K, Kitamura N, Maruyama H.

Measurement of the length of vertebrobasilar arteries: A three-dimensional approach. J Neurol Sci. 414: 116818, 2020.

 

●Kurashige T, Murao T, Mine N, Sugiura T, Inazuka Y, Kuraoka K, Takahashi T, Maruyama H, Torii T.

Anti-HMGCR Antibody-Positive Myopathy Shows Bcl-2-Positive Inflammation and Lymphocytic Accumulations. J Neuropathol Exp Neurol. 79(4): 448-457, 2020.

 

●Naito H, Hosomi N, Kuzume D, Nezu T, Aoki S, Morimoto Y, Kinboshi M, Yoshida T, Shiga Y, Kinoshita N, Ueno H, Noma K, Yamasaki M, Maruyama H.

Increased blood pressure variability during the subacute phase of ischemic stroke is associated with poor functional outcomes at 3 months. Sci Rep. 10(1): 811, 2020.

 

●Kume K, Takata T, Morino H, Matsuda Y, Ohsawa R, Tada Y, Kurashige T, Kawakami H.
 The first Japanese case of primary familial brain calcification caused by an MYORG variant. J Hum Genet. 65(10): 917-920, 2020.

 

●Mizuno N, Iwata T, Ohsawa R, Ouhara K, Matsuda S, Kajiya M, Matsuda Y, Kume K, Tada Y, Morino H, Yoshimoto T, Ueki Y, Mihara K, Sotomaru Y, Takeda K, Munenaga S, Fujita T, Kawaguchi H, Shiba H, Kawakami H, Kurihara H.

Optineurin regulates osteoblastogenesis through STAT1. Biochem Biophys Res Commun. 525(4): 889-894, 2020.

 

●Kume K, Morino H, Miyamoto R, Matsuda Y, Ohsawa R, Kanaya Y, Tada Y, Kurashige T, Kawakami H.

Middle-age-onset cerebellar ataxia caused by a homozygous TWNK variant: a case report. BMC Med Genet. 21(1): 68. 2020.

 

●Mizuno N, Kume K, Nagatani Y, Matsuda S, Iwata T, Ouhara K, Kajiya M, Takeda K, Matsuda Y, Tada Y, Ohsawa R, Morino H, Mihara K, Fujita T, Kawaguchi H, Shiba H, Kawakami H, Kurihara H.

Aggressive periodontitis and NOD2 variants. J Hum Genet. 65(10): 841-846, 2020.

 

●Uwatoko H, Nakamori M, Imamura E, Imura T, Okada K, Matsumae Y, Okamoto H, Wakabayashi S.

Prediction of independent gait in acute stroke patients with hemiplegia using the Ability for Basic Movement Scale II score, Eur Neurol. 83(1): 49-55, 2020.

 

●Nishi H, Hosomi N, Ohta K, Aoki S, Nakamori M, Nezu T, Shigeishi H, Shintani T, Obayashi T, Ishikawa K, Kinoshita N, Shiga Y, Sugiyama M, Ohge H, Maruyama H, Kawaguchi H, Kurihara H.

Serum IgG antibody titer to Fusobacterium nucleatum is associated with unfavorable outcome after stroke. Clin Exp Immunol. 200(3): 302-309, 2020.

 

●Aoki S, Hosomi N, Nishi H, Nakamori M, Nezu T, Shiga Y, Kinoshita N, Ueno H, Ishikawa K, Imamura E, Shintani T, Ohge H, Kawaguchi H, Kurihara H, Maruyama H.

Serum IgG titers to periodontal pathogens predict 3-month outcome in ischemic stroke patients. PLoS One. 15(8): e0237185, 2020.

 

●Nakamori M, Hosomi N, Tachiyama K, Kamimura T, Matsushima H, Hayashi Y, Imamura E, Wakabayashi S, Maruyama H.

Lobar microbleeds are associated with cognitive impairment in patients with lacunar infarction. Sci Rep. 10(1): 16410, 2020.

 

●Nakamori M, Hosomi N, Nishi H, Aoki S, Nezu T, Shiga Y, Kinoshita N, Ishikawa K, Imamura E, Shintani T, Ohge H, Kawaguchi H, Kurihara H, Wakabayashi S, Maruyama H.

Serum IgG titers against periodontal pathogens are associated with cerebral hemorrhage growth and 3-month outcome. PLos One. 15(10): e0241205, 2020.

 

●Shiga Y, Hosomi N, Nezu T, Nishi H, Aoki S, Nakamori M, Ishikawa K, Kinoshita N, Imamura E, Ueno H, Shintani T, Ohge H, Kawaguchi H, Kurihara H, Wakabayashi S, Maruyama H.

Association between periodontal disease due to Campylobacter rectus and cerebral microbleeds in acute stroke patients. PLos One. 15(10): e0239773, 2020.

 

●Shrestha T, Takahashi T, Li C, Matsumoto M, Maruyama H.

Nicotine-induced upregulation of miR-132-5p enhances cell survival in PC12 cells by targeting the anti-apoptotic protein Bcl-2. Neurol Res. 42(5): 405-414, 2020.

 

●Hara N, Morino H, Matsuda Y, Satoh K, Hashimoto K, Maruyama H, Kawakami H.

Zonisamide can ameliorate the voltage-dependence alteration of the T-type calcium channel Ca V 3.1 caused by a mutation responsible for spinocerebellar ataxia. Mol Brain. 13(1): 163, 2020.

 

●Takeda C, Yoshida M, Nakamori M, Hosomi N, Nagasaki T, Yoshikawa M, Kayashita J, Masuda S, Maruyama H, Tsuga K.

Delayed Swallowing Reflex is Overlooked in Swallowing Screening Among Acute Stroke Patients. J Stroke Cerebrovasc Dis. 29(12): 105303, 2020.

 

●Nakamori M, Imamura E, Kuwabara M, Ayukawa T, Tachiyama K, Kamimura T, Hayashi Y, Matsushima H, Funai M, Mizoue T, Wakabayashi S.

Simplified cough test can predict the risk for pneumonia in patients with acute stroke. PLoS One. 15(9): e0239590, 2020.

 

●Nakamori M, Imamura E, Fukuta M, Tachiyama K, Kamimura T, Hayashi Y, Matsushima H, Ogawa K, Nishino M, Hirata A, Mizoue T, Wakabayashi S.

Tongue thickness measured by ultrasonography is associated with tongue pressure in the Japanese elderly. PLoS One. 15(8): e0230224, 2020.

 

●Nakamori M, Imamura E, Tachiyama K, Kamimura T, Hayashi Y, Matsushima H, Okamoto H, Mizoue T, Wakabayashi S.

Patient Health Questionnaire-9 predicts the functional outcome of stroke patients in convalescent rehabilitation ward. Brain Behav. 10(12): e01856, 2020.

 

●Sugimoto T, Ochi K, Ishikawa R, Tazuma T, Hayashi M, Mine N, Naito H, Nomura E, Kohriyama T, Yamawaki T.

Initial deterioration and intravenous methylprednisolone therapy in patients with myasthenia gravis. J Neurol Sci. 412: 116740, 2020.

 

●Akiyama T, Oiwa H, Hayashi M, Sugimoto T, Nomura E, Yamawaki T.

Aseptic meningitis as an initial presentation of Sjögren syndrome: a report of two cases and literature review. Nagoya J Med Sci. 82(3): 595-602, 2020.

 

●Yamada H, Nishikawa T, Yamasaki M, Fukuba H, Ohmori H, Nakamura M, Miyachi T.

Deep vein thrombosis in patients with neuromuscular disease who undergo tracheotomy with positive pressure ventilation. Neurology and Clinical Neuroscience. 9(1): 63-76, 2020.

 

●Sugimoto T, Takasuka H, Ishikawa R, Tazuma T, Hayashi M, Mine N, Naito H, Nomura E, Shiote Y, Yamawaki T.

Leptomeningeal myelomatosis with hypertrophy of the cauda equina nerve roots: A case report. Neurol Clin Neurosci. 8: 403-405, 2020.

 

●Kurashige T, Morino H, Matsuda Y, Mukai T, Murao T, Toko M, Kume K, Ohsawa R, Torii T, Tokinobu H, Maruyama H, Kawakami H.
Retinitis pigmentosa prior to familial ALS caused by a homozygous cilia and flagella-associated protein 410 mutation. J Neurol Neurosurg Psychiatry. 91(2): 220-222, 2020.

 

●Nezu T, Hosomi N, Kitagawa K, Nagai Y, Nakagawa Y, Aoki S, Kagimura T, Maruyama H, Origasa H, Minematsu K, Uchiyama S, Matsumoto M; J-STARS collaborators.

Effect of Statin on Stroke Recurrence Prevention at Different Infarction Locations: A Post Hoc Analysis of The J-STARS Study. J Atheroscler Thromb. 27(6): 524-533, 2020.

 

●Ueno H, Iizuka T, Tagane Y, Yamasaki F, Akiyama Y, Hosomi N, Maruyama H.
 Focal hyperperfusion and elevated lactate in the cerebral lesions with anti-GABAaR encephalitis: A serial MRI study. J Neuroradiol. 47(3): 243-246, 2020.

 

●Obayashi H, Nagano Y, Takahashi T, Seki T, Tanaka S, Sakai N, Matsumoto M, Maruyama H.

Histone deacetylase 10 knockout activates chaperone-mediated autophagy and accelerates the decomposition of its substrate. Biochem Biophys Res Commun. 523(1): 246-252, 2020.

 

●Shiga Y, Nezu T, Hosomi N, Aoki S, Nishi H, Naito H, Kinoshita N, Ueno H, Maruyama H.

Effect of tooth loss and nutritional status on outcomes after ischemic stroke. Nutrition. 71:110606, 2020.

 

●Kurashige T, Morino H, Matsuda Y, Mukai T, Murao T, Toko M, Kume K, Ohsawa R, Torii T, Tokinobu H, Maruyama H, Kawakami H.
Retinitis pigmentosa prior to familial ALS caused by a homozygous cilia and flagella-associated protein 410 mutation. J Neurol Neurosurg Psychiatry. 91(2): 220-222, 2020.

英文総説

●Nezu T, Hosomi N.

Usefulness of Carotid Ultrasonography for Risk Stratification of Cerebral and Cardiovascular Disease. J Atheroscler Thromb. 27(10): 1023-1035, 2020.

 

 

<2019年>

英文原著

●Tokunaga K, Koga M, Itabashi R, Yamagami H, Todo K, Yoshimura S, Kimura K, Sato S, Terasaki T, Inoue M, Shiokawa Y, Takagi M, Kamiyama K, Tanaka K, Takizawa S, Shiozawa M, Okuda S, Okada Y, Kameda T, Nagakane Y, Hasegawa Y, Shibuya S, Ito Y, Matsuoka H, Takamatsu K, Nishiyama K, Kario K, Yagita Y, Fujita K, Ando D, Kumamoto M, Arihiro S, Toyoda K. for the SAMURAI Study Investigators.

Prior Anticoagulation and Short- or Long-Term Clinical Outcomes in Ischemic Stroke or TIA Patients with NVAF. J Am Heart Assoc. 8(3): e010593, 2019.

 

●Shishido T, Nagano Y, Araki M, Kurashige T, Obayashi H, Nakamura T, Takahashi T, Matsumoto M, Maruyama H.

Synphilin-1 has neuroprotective effects on MPP+-induced Parkinson's disease model cells by inhibiting ROS production and apoptosis. Neurosci Lett. 690:145-150, 2019.

 

●Hosomi N, Kitagawa K, Nagai Y, Nakagawa Y, Aoki S, Nezu T, Kagimura T, Maruyama H, Origasa H, Minematsu K, Uchiyama S, Matsumoto M; for J-STARS collaborators.

Different influences of statin treatment in preventing at-risk stroke subtypes. A post hoc analysis of J-STARS. J Atheroscler Thromb. Sep 18, 2019.

 

●Godolphin PJ, Bath PM, Algra A, Berge E, Brown MM, Chalmers J, Duley L, Eliasziw M, Gregson J, Greving JP, Hankey GJ, Hosomi N, Johnston SC, Patsko E, Ranta A, Sandset PM, Serena J, Weimar C, Montgomery AA, on behalf of the Adjudicating Outcomes in Stroke Trials Collaboration.

Outcome assessment by central adjudicators vs site investigators in stroke trials: A systematic review and meta-analysis. Stroke. 2019 in press.

 

●Shimomura R, Hosomi N, Tsunematsu M, Mukai T, Sueda Y, Shimoe Y, Ohshita T, Torii T, Nezu T, Aoki S, Kakehashi M, Matsumoto M, Maruyama H; the Hiroshima ‘Emergency and Weather’ Study-stroke collaborators.

Warm front passage on the previous day increased ischemic stroke events. J Stroke Cerebrovasc Dis. 28(7): 1873-1878, 2019.

 

●Wada S, Koga M, Minematsu K, Toyoda K, Suzuki R, Kagimura T, Nagai Y, Aoki S, Nezu T, Hosomi N, Origasa H, Ohtsuki T, Maruyama H, Yasaka M, Kitagawa K, Uchiyama S, Matsumoto M.

Baseline Carotid Intima-Media Thickness and Stroke Recurrence During Secondary Prevention With Pravastatin. Stroke. 50(6): 1586-1589, 2019.

 

●Fukuoka Y, Hosomi N, Hyakuta T, Omori T, Ito Y, Uemura J, Yagita Y, Kimura K, Matsumoto M, Moriyama M; DMP Stroke Trial Investigators.

Effects of a disease management program for preventing recurrent ischemic stroke: A randomized controlled study. Stroke. 50(3): 705-712, 2019.

 

●Kitagawa K, Hosomi N, Nagai Y, Kagimura T, Ohtsuki T, Origasa H, Minematsu K, Uchiyama S, Nakamura M, Matsumoto M; J-STARS collaborators.

Cumulative Effects of LDL Cholesterol and CRP Levels on Recurrent Stroke and TIA. J Atheroscler Thromb. 26(5): 432-441, 2019.

 

●Neshige S, Matsumoto R, Inouchi M, Kobayashi K, Shimotake A, Maruyama H, Takahashi R, Ikeda A.

Absence of an Autonomic Sign Assists in the Diagnosis of Extratemporal Lobe Epilepsy Manifesting Generalized Convulsion with Retained Awareness. Intern Med. 58(8): 1151-1155, 2019.

 

●Ueno H, Norose K, Kamimura T, Mihara K, Yamasaki F, Hikosaka K, J Amatya V, Takeshima Y, Kurisu K, Maruyama H.

Metastatic Malignant Lymphoma Mimicking Cerebral Toxoplasmosis with the "Target Sign". Intern Med. 58(8): 1157-1162, 2019.

 

●Kitagawa K, Hosomi N, Nagai Y, Kagimura T, Ohtsuki T, Maruyama H, Origasa H, Minematsu K, Uchiyama S, Nakamura M, Matsumoto M; J-STARS collaborators.

Cumulative Effects of LDL Cholesterol and CRP Levels on Recurrent Stroke and TIA. J Atheroscler Thromb. 26(5): 432-441, 2019.

 

●Kolakshyapati M, Hashizume A, Ochi K, Ueno H, Kaichi Y, Takayasu T, Takano M, Karlowee V, Akiyama Y, Awai K, Maruyama H, Sugiyama K, Kurisu K, Yamasaki F.

Usefulness of Histogram-Profile Analysis in Ring-Enhancing Intracranial Lesions. World Neurosurg. 131: e226-e236, 2019.

 

●Neshige S, Kobayashi K, Matsuhashi M, Togo M, Sakamoto M, Shimotake A, Hitomi T, Kikuchi T, Yoshida K, Kunieda T, Matsumoto R, Maruyama H, Takahashi R, Miyamoto S, Ikeda A.

A score to map the lateral nonprimary motor area: Multispectrum intrinsic brain activity versus cortical stimulation. Epilepsia. 60(11): 2294-2305, 2019.

 

●Neshige S, Kobayashi K, Matsuhashi M, Hitomi T, Shimotake A, Kikuchi T, Yoshida K, Kunieda T, Matsumoto R, Miyamoto S, Takahashi R, Maruyama H, Ikeda A.

A rational, multispectral mapping algorithm for primary motor cortex: A primary step before cortical stimulation. Epilepsia. 60(3): 547-559, 2019.

 

●Oi K, Neshige S, Hitomi T, Kobayashi K, Tojima M, Matsuhashi M, Shimotake A, Fujii D, Matsumoto R, Kasama S, Kanda M, Wada Y, Maruyama H, Takahashi R, Ikeda A.

Low-dose perampanel improves refractory cortical myoclonus by the dispersed and suppressed paroxysmal depolarization shifts in the sensorimotor cortex. Clin Neurophysiol. 130(10): 1804-1812, 2019.

 

●Yamasaki T, Aso T, Kaseda Y, Mimori Y, Doi H, Matsuoka N, Takamiya N, Torii T, Takahashi T, Ohshita T, Yamashita H, Doi H, Inamizu S, Chatani H, Tobimatsu S.

Decreased stimulus-driven connectivity of the primary visual cortex during visual motion stimulation in amnestic mild cognitive impairment. Neurosci Lett. 711: 134402, 2019.

 

●Zhang X, Yamashita S, Hara K, Doki T, Tawara N, Ikeda T, Misumi Y, Zhang Z, Matsuo Y, Nagai M, Kurashige T, Maruyama H, Ando Y.

A mutant MATR3 mouse model to explain multisystem proteinopathy. J Pathol. 249(2): 182-192, 2019.

 

● Maetani Y, Nezu T, Ueno H, Aoki S, Hosomi N, Maruyama H.
Steroid-responsive Nivolumab-induced Involuntary Movement with Anti-thyroid Antibodies. Intern Med. 58(24): 3577-3581, 2019.

 

●Kamimura T, Okazaki S, Morimoto T, Kobayashi H, Harada K, Tomita T, Higashiyama A, Yoshimoto T, Takahashi JC, Nakagawara J, Koga M, Toyoda K, Maruyama H, Koizumi A, Ihara M.

Prevalence of RNF213 p.R4810K Variant in Early-Onset Stroke With Intracranial Arterial Stenosis. Stroke.  50(6): 1561-1563, 2019.

 

●Doki T, Yamashita S, Wei FY, Hara K, Yamamoto T, Zhang Z, Zhang X, Tawara N, Hino H, Uyama E, Kurashige T, Maruyama H, Tomizawa K, Ando Y.

Mitochondrial localization of PABPN1 in oculopharyngeal muscular dystrophy. Lab Invest. 99(11): 1728-1740, 2019.

 

●Nishikawa Y, Watanabe K, Kawade S, Takahashi T, Kimura H, Maruyama H, Hyngstrom A. The effect of a portable electrical muscle stimulation device at home on muscle strength and activation patterns in locomotive syndrome patients: A randomized control trial. J Electromyogr Kinesiol. 45: 46-52, 2019.

 

●Maetani Y, Nakamori M, Imamura E, Ishii Y, Aihara H, Suyama Y, Wakabayashi S, Maruyama H.
Utility of Minimum Apparent Diffusion Coefficient Ratios in Alberta Stroke Program Early CT Score Regions for Deciding on Stroke Therapy. J Stroke Cerebrovasc Dis. 28(5):1371-1380, 2019.

 ●Fujita K, Matsubara T, Miyamoto R, Sumikura H, Takeuchi T, Maruyama Saladini K, Kawarai T, Nodera H, Udaka F, Kume K, Morino H, Kawakami H, Hasegawa M, Kaji R, Murayama S, Izumi Y.

Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report. BMC Neurol. 19(1): 168, 2019.

 

●Kume K, Morino H, Komure O, Matsuda Y, Ohsawa R, Kurashige T, Kanaya Y, Tada Y, Kawakami H.

C-terminal mutations in SYNE1 are associated with motor neuron disease in patients with SCAR8. J Neurol Sci. 15;402: 118-120, 2019.

 

●Matsubara T, Oda M, Takahashi T, Watanabe C, Tachiyama Y, Morino H, Kawakami H, Kaji R, Maruyama H, Murayama S, Izumi Y.

Amyotrophic lateral sclerosis of long clinical course clinically presenting with progressive muscular atrophy. Neuropathology. 39(1): 47-53, 2019.

 

●Hara N, Nezu T, Kobatake K, Morino H, Kawakami H, Maruyama H.

Treatment of intractable resting tremor of spinocerebellar ataxia 42 with zonisamide. J Neurol Sci. 396: 119-120, 2019.

 

●Ramos A, Planchat M, Vieira Melo AR, Raposo M, Shamim U, Suroliya V, Srivastava AK, Faruq M, Morino H, Ohsawa R, Kawakami H, Jardim LB, Saraiva-Pereira ML, Vasconcelos J, Santos C, Lima M.

Mitochondrial DNA haplogroups and age at onset of Machado-Joseph disease/Spinocerebellar ataxia type 3: a study in patients from multiple populations. Eur J Neurol. 26(3): 506-512, 2019.

 

●Satoh A, Hirashio S, Arima T, Yamada Y, Irifuku T, Ishibashi H, Motoda A, Sueda Y, Masaki T.

Novel Asp511Thr mutation in McArdle disease with acute kidney injury caused by rhabdomyolysis. CEN Case Rep. 8(3): 194-199, 2019.

 

●Kamimura T, Tanaka K, Yamagami H, Koga M.

Cerebral Embolism due to a Large Papillary Fibroelastoma arising from the Coumadin Ridge. Clin Case Rep. 7(6): 1267-1268, 2019.

 

 

<2018年>

英文原著

●Takayasu T, Yamasaki F, Shishido T, Takano M, Maruyama H, Sugiyama K, Kurisu K.

Abscess Formation in Metastatic Brain Tumor with History of Immune Checkpoint Inhibitor: A Case Report. NMC Case Rep J. 6(1): 11-15, 2018.

 

●Kitamura J, Ueno H, Nagai M, Hosomi N, Honjo K, Nakamori M, Mukai T, Imamura E, Nezu T, Aoki S, Ohshita T, Nomura E, Wakabayashi S, Maruyama H, Matsumoto M.

Blood Pressure Variability in Acute Ischemic Stroke: Influence of Infarct Location in the Insular Cortex. Eur Neurol. 79(1-2): 90-99, 2018.

 

●Kinoshita N, Hosomi N, Matsushima H, Nakamori M, Yagita Y, Yamawaki T, Torii T, Kitamura T, Sueda Y, Shimomura R, Araki M, Nezu T, Aoki S, Ishii S, Maruyama H, Matsumoto M, Maruyama H.

Screening for Fabry Disease in Japanese Patients with Young-Onset Stroke by Measuring α-Galactosidase A and Globotriaosylsphingosine. J Stroke Cerebrovasc Dis. 27(12): 3563-3569, 2018.

 

●Li C, Takahashi T, Shrestha T, Kinoshita E, Matsubara T, Matsumoto M, Maruyama H.

4',6-Diamidino-2-Phenylindole Distinctly Labels Tau Deposits. J Histochem Cytochem. 66(10): 737-751, 2018.

 

●Naito H, Nezu T, Hosomi N, Aoki S, Ueno H, Ochi K, Maruyama H.

Antithrombotic Therapy Strategy for Cancer-Associated Ischemic Stroke: A Case Series of 26 Patients. J Stroke Cerebrovasc Dis. 27(9): e206-e211, 2018.

 

●Naito H, Nezu T, Hosomi N, Aoki S, Kinoshita N, Kuga J, Shimomura R, Araki M, Ueno H, Ochi K, Maruyama H.

Controlling Nutritional Status score for predicting 3-mo functional outcome in acute ischemic stroke. Nutrition. 55-56: 1-6, 2018.

 

●Neshige S, Matsuhashi M, Kobayashi K, Sakurai T, Shimotake A, Hitomi T, Kikuchi T, Yoshida K, Kunieda T, Matsumoto R, Takahashi R, Miyamoto S, Maruyama H, Matsumoto M, Ikeda A.

Multi-component intrinsic brain activities as a safe alternative to cortical stimulation for sensori-motor mapping in neurosurgery. Clin Neurophysiol. 129(9): 2038-2048, 2018.

 

●Nishikawa Y, Watanabe K, Takahashi T, Kimura H, Maruyama H.

The effect of medication on vastus lateralis muscle activation patterns in Parkinson's disease patients. J Electromyogr Kinesiol. 42: 66-73, 2018.

 

●Kinoshita N, Saito K, Yamaguchi Y, Abe S, Wada S, Tanaka T, Kajimoto K, Yamagami H, Maruyama H, Toyoda K, Ihara M, Nagatsuka K.

Flip-Flop Phenomenon: Swallowing-Induced Arterial Displacement as an Indicator of Carotid Artery Disease. Cerebrovasc Dis. 45(5-6): 258-262, 2018.

 

●Nishikawa Y, Kokubun T, Kanemura N, Takahashi T, Matsumoto M, Maruyama H, Takayanagi K.

Effects of controlled abnormal joint movement on the molecular biological response in intra-articular tissues during the acute phase of anterior cruciate ligament injury in a rat model.  BMC Musculoskelet Disord. 19(1): 175, 2018.

 

●Hosomi N, Kitagawa K, Nagai Y, Nakagawa Y, Aoki S, Nezu T, Kagimura T, Maruyama H, Origasa H, Minematsu K, Uchiyama S, Matsumoto M; J-STARS Collaborators.

Desirable Low-Density Lipoprotein Cholesterol Levels for Preventing Stroke Recurrence: A Post Hoc Analysis of the J-STARS Study (Japan Statin Treatment Against Recurrent Stroke). Stroke. 49(4): 865-871, 2018.

 

●Nezu T, Kitano T, Kubo S, Uemura J, Yamashita S, Iwanaga T, Inoue T, Hosomi N, Maruyama H, Matsumoto M, Kimura K, Yagita Y.

Impact of D-dimer levels for short-term or long-term outcomes in cryptogenic stroke patients. J Neurol. 265(3): 628-636, 2018.

 

●Neshige S, Neshige R.

Shifting laxative dosing schedule to an earlier time improves refractory constipation in Parkinson's disease: a case series. Neurology and Clinical Neuroscience, 6: 182-184, 2018.

 

●Hemmi S, Kurokawa K, Nagai T, Asano A, Okamoto T, Murakami T, Mihara M, Sunada Y.

Influence of placement sites of the active recording electrode on CMAP con- figuration in the trapezius muscle. Clin Neurophysiol Pract. 3: 54-58, 2018.

 

●Matsubara T, Kurokawa K, Sakurai K, Yasutomi H, Yamawaki T.

The Gilliatt-Sumner hand: a diagnostic clue of neurogenic thoracic outlet syndrome. QJM. 111(11): 831-832, 2018.

 

●Kikumoto M, Nagai M, Ohshita T, Toko M, Kato M, Dote K, Yamashita H.

Insular cortex lesion and autonomic instability in a herpes simplex virus encephalitis patient. J Neurovirol. 24(5): 649-651, 2018.

 

●Nagai M, Kikumoto M, Ohshita T, Kato M, Yamashita H, Dote K.

Letter to the Editor Regarding "Autonomic Function in Insular Glioma: An Exploratory Study". World Neurosurg. 119: 461, 2018.

 

●Nagai M, Kikumoto M, Ohshita T, Kato M, Yamashita H, Dote K.

Right Insular Cortex Ischemia Caused by Middle Cerebral Artery Occlusion: A Possible Pathogenesis of Decreased Sympathetic Nervous System Activity? Neurologist. 23(6): 197, 2018.

 

●Shiga Y, Kuriyama M, Tachiyama K, Kanaya Y, Takemaru M, Takeshima S, Takamatsu K, Shimoe Y, Tanaka A.

MR T2 high image of longus colli muscle without tendinous calcification; A suggestive sign of cervical spinal infection. eNeurologicalSci. 13: 49-50, 2018.

 

●Izumi Y, Morino H, Miyamoto R, Matsuda Y, Ohsawa R, Kurashige T, Shimatani Y, Kaji R, Kawakami H.

Compound heterozygote mutations in the SIGMAR1 gene in an oldest old patient with amyotrophic lateral sclerosis.Geriatr Gerontol Int. 18(10): 1519-1520, 2018.

 

●Tawara N, Yamashita S, Kawakami K, Kurashige T, Zhang Z, Tasaki M, Yamamoto Y, Nishikami T, Doki T, Zhang X, Matsuo Y, Kimura E, Tawara A, Maeda Y, Hauschka SD, Maruyama H, Ando Y.

Muscle dominant wild type TDP-43 expression induces myopathological changes featuring tubular aggregates and TDP-43 positive inclusions. Exp Neurol. 309: 169-180, 2018.

 

●Oiwa H, Kurashige T.

Muscle weakness as a presenting symptom in ANCA-associated vasculitis. Eur J Rheumatol. 5(2): 139-141, 2018.

 

●Haji S, Eto F, Torii T. 

Multijoint Pain and Pulmonary Calcification with Long-term Hemodialysis. Intern Med. 57(20): 3063-3064, 2018.

 

●Tokunaga K, Yamagami H, Koga M, Todo K, Kimura K, Furui E, Terasaki T, Shiokawa Y, Kamiyama K, Takizawa S, Okuda S, Okada Y, Kameda T, Nagakane Y, Hasegawa Y, Shibuya S, Ito Y, Matsuoka H, Takamatsu K, Nishiyama K, Kario K, ●Yagita Y, Kitazono T, Kinoshita N, Takasugi J, Okata T, Yoshimura S, Arihiro S, Toyoda K.

Associations between pre-admission risk scores and two-year clinical outcomes in ischemic stroke or transient ischemic attack patients with non-valvular atrial fibrillation. Cerebrovasc Dis. 45(3-4): 170-179, 2018.

 

●Yoshimura S, Koga M, Sato S, Todo K, Yamagami H, Kumamoto M, Furui E, Terasaki T, Kimura K, Yagita Y, Shiokawa Y, Kamiyama K, Okuda S, Okada Y, Takizawa S, Hasegawa Y, Kameda T, Shibuya S, Nagakane Y, Ito Y, Matsuoka H, Takamatsu K, Nishiyama K, Fujita K, Kamimura T, Ando D, Ide T, Yoshimoto T, Shiozawa M, Matsubara S, Yamaguchi Y, Kinoshita N, Matsuki T, Takasugi J, Tokunaga K, Higashida K, Homma K, Kario K, Arihiro S, Toyoda K. for the SAMURAI Study Investigators.

Two-year outcomes of anticoagulation for acute ischemic stroke with non-valvular atrial fibrillation: SAMURAI-NVAF study. Circ J. 82(7): 1935-1942, 2018.

 

●Maetani Y, Nakamori M, Watanabe T, Matsushima H, Imamura E, Wakabayashi S.  Subarachnoid hemorrhage after transient global amnesia caused by cerebral venous congestion: case report, BMC Neurology. 18(1): 36, 2018.

 

●Sugimoto T, Ochi K, Kitamura T, Muguruma K, Kohriyama T, Matsumoto M, Maruyama H.

Ultrasonographic measurement of cross-sectional area of the median and ulnar nerves in healthy Japanese children. Neurosonology. 31(3):120-124, 2018.

 

●Miura T, Mezaki N, Konno T, Iwasaki A, Hara N, Miura M, Funayama M, Unai Y, Tashiro Y, Okita K, Kihara T, Ito N, Kanatsuka Y, Jones DT, Hara N, Ishiguro T, Tokutake T, Kasuga K, Nozaki H, Dickson DW, Onodera O, Wszolek ZK, Ikeuchi T.
 Identification and functional characterization of novel mutations including frameshift mutation in exon 4 of CSF1R in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. J Neurol. 265(10): 2415-2424, 2018.

 

●Yamasaki F, Takayasu T, Nosaka R, Haratake D, Arihiro K, Ueno H, Shimomura R, Akiyama Y, Sugiyama K, Matsumoto M, Kurisu K.
Transient spontaneous regression of brainstem glioblastoma. J Neurosurg Sci. 62(5): 610-612, 2018.

 

●Oiwa H, Kurashige T.

Muscle weakness as a presenting symptom in ANCA-associated vasculitis. Eur J Rheumatol. 5(2): 139-141, 2018.

 

●Nezu T, Hosomi N, Aoki S, Suzuki N, Teshima T, Sugii H, Nagahama S, Kurose Y, Maruyama H, Matsumoto M.

Effects of Cilnidipine, an L/N-Type Calcium Channel Blocker, on Carotid Atherosclerosis in Japanese Post-Stroke Hypertensive Patients: Results from the CA-ATTEND Study. J Atheroscler Thromb. 25(6): 490-504, 2018.

 

●Wada S, Koga M, Toyoda K, Minematsu K, Yasaka M, Nagai Y, Aoki S, Nezu T, Hosomi N, Kagimura T, Origasa H, Kamiyama K, Suzuki R, Ohtsuki T, Maruyama H, Kitagawa K, Uchiyama S, Matsumoto M. Japan Statin Treatment Against Recurrent Stroke (J-STARS) Echo Study Collaborators.

Factors Associated with Intima-Media Complex Thickness of the Common Carotid Artery in Japanese Noncardioembolic Stroke Patients with Hyperlipidemia: The J-STARS Echo Study. J Atheroscler Thromb. 25(4): 359-373, 2018.

 

●Shimomura R, Nezu T, Hosomi N, Aoki S, Sugimoto T, Kinoshita N, Araki M, Takahashi T, Maruyama H, Matsumoto M.

Alpha-2-macroglobulin as a Promising Biological Marker of Endothelial Function. J Atheroscler Thromb. 25(4): 350-358, 2018.

 

 

<2017年>

英文原著

●Fujii H, Takahashi T, Mukai T, Tanaka S, Hosomi N, Maruyama H, Sakai N, Matsumoto M.

Modifications of tau protein after cerebral ischemia and reperfusion rats are similar to those occurring in Alzheimer’s disease-hyperphosphorylation and cleavage of 4-and 3-repeat tau. J Cereb Blood Flow Metab. 37: 2441-2457, 2017.

 

●Murata-Shinozaki Y, Takahashi T, Matsubara T, Maruyama H, Izumi Y, Matsumoto M.

The origins of rimmed vacuoles and granulovacuolar degeneration bodies are associated with the Wnt signaling pathway. Neurosci Lett. 638: 55-59, 2017.

 

●Hemmi S, Kurokawa K, Nagai T, Kushida R, Okamoto T, Murakami T, Sunada Y. Variations in the distal branches of the superficial fibular sensory nerve. Muscle Nerve. 55: 74-76, 2017.

 

●Kitano T, Nezu T, Shiromoto T, Kubo S, Uemura J, Wada Y, Yagita Y.  Association between absolute eosinophil count and complex aortic arch plaque in patients with acute ischemic stroke. Stroke. 48. 1074-1076. 2017.

 

●Mukai T, Hosomi N, Tsunematsu M, Sueda Y, Ohshita T, Aoki S, Maruyama H, Kakehashi M, Matsumoto M. Hiroshima Emergency and Weather Study-stroke collaborators.

Various meteorological conditions exhibit both immediate and delayed influences on the risk of stroke events: The HEWS-stroke study. PLoS One.  12(6): e0178223, 2017.

 

●Naito H, Takahashi T, Kamada M, Morino H, Yoshino H, Hattori N, Maruyama H, Kawakami H, Matsumoto M.

First report of a Japanese family with spinocerebellar ataxia type 10: The second report from Asia after a report from China. PLoS One. 12(5): e0177955,2017.

 

●Matsushima H, Hosomi N, Hara N, Yoshimoto T, Neshige S, Kono R, Himeno T, Takeshima S, Takamatsu K, Shimoe Y, Ota T, Maruyama H, Ohtsuki T, Kuriyama M, Matsumoto M.

Ability of the Ankle Brachial Index and Brachial-Ankle Pulse Wave Velocity to Predict the 3-Month Outcome in Patients with Non-Cardioembolic Stroke. J Atheroscler Thromb. 24: 1167-1173, 2017.

 

●Aoki S, Hosomi N, Nezu T, Teshima T, Sugii H, Nagahama S, Kurose Y, Maruyama H, Matsumoto M.

Blood pressure control with cilnidipine treatment in Japanese post-stroke hypertensive patients: The CA-ATTEND study. Clin Exp Hypertens. 39: 225-234, 2017.

 

●Hiraoka A, Yoshikawa M, Nakamori M, Hosomi N, Nagasaki T, Mori T, Oda M, Maruyama H, Yoshida M, Izumi Y, Matsumoto M, Tsuga K.

Maximum Tongue Pressure is Associated with Swallowing Dysfunction in ALS Patients. Dysphagia. 32: 542-547, 2017.

 

●Kubo S, Hosomi N, Hara N, Neshige S, Himeno T, Takeshima S, Takamatsu K, Shimoe Y, Ota T, Maruyama H, Ohtsuki T, Kuriyama M, Matsumoto M.

Ischemic Stroke Mortality Is More Strongly Associated with Anemia on Admission Than with Underweight Status. J Stroke Cerebrovasc Dis. 26: 1369-1374, 2017.

 

●Nishikawa Y, Watanabe K, Takahashi T, Hosomi N, Orita N, Mikami Y, Maruyama H, Kimura H, Matsumoto M.

Sex differences in variances of multi-channel surface electromyography distribution of the vastus lateralis muscle during isometric knee extension in young adults. Eue J Appl Physiol. 117: 583-589, 2017.

 

●Kitagawa K, Hosomi N, Nagai Y, Kagimura T, Ohtsuki T, Origasa H, Minematsu K, Uchiyama S, Nakamura M, Matsumoto M．

J-STARS Investigators. Reduction in High-Sensitivity C-Reactive Protein Levels in Patients with Ischemic Stroke by Statin Treatment: Hs-CRP Sub-Study in J-STARS. J Atheroscler Thromb. 24: 1039-1047, 2017.

 

●Nakamura M, Fukukawa T, Kitagawa K, Nagai Y, Hosomi N, Matsumoto M, Minematsu K, Uchiyama S, Miyamoto Y.

ANNALS EXPRESS: Ten-year standardization of lipids and high-sensitivity C-reactive protein in a randomized controlled trial to assess effects of statins on secondary stroke prevention: Japan Statin Treatment Against Recurrent Stroke (J-STARS). Ann Clin Biochem. 55: 128-135, 2017.

 

●Kaseda Y, Ikeda J, Sugihara K, Yamawaki T, Kohriyama T, Matsumoto M.

Therapeutic effects of intensive inpatient rehabilitation in advanced Parkinson's disease. Neurol Clin Neurosci. 5: 18-21, 2017.

 

●Yamamoto T, Toki S, Greg J. Siegle, Takamura M, Takaishi Y, Yoshimura S, Okada G, Matsumoto T, Nakao T, Muranaka H, Kaseda Y, Murakami T, Okamoto Y. Yamawaki T.　

Increased amygdala reactivity following early life stress: a potential resilience enhancer role. BMC Psychiatry. 17: 27, 2017.

 

●Kitano T, Nezu T, Mukai T, Uemura J, Wada Y, Yagita Y.

A case of hypertensive encephalopathy with enlarged optic nerve sheath measured by transorbital sonography. J Stroke Cerebrovasc Dis. 26: e20-e21, 2017.

 

●Hemmi S, Kurokawa K, Nagai T, Kushida R, Okamoto T, Murakami T, Sunada Y.

A new technique for dorsal sural nerve conduction study with surface strip electrodes. Clin Neurophysiol 128: 1214-1219, 2017.

 

●Oiwa H, Mokuda S, Matsubara T, Funaki M, Takeda I, Yamawaki T, Kumagai K, Sugiyama E.　Neurological complications in eosinophilic granuomatosis with polyangiitis (EPGA): the roles of history and the results of physical examinations in the diagnosis of EPGA. Intern Med. 56: 3003-3008, 2017.

 

●Oiwa H, Yamabe T, Kawashima M, Maetani Y, Agari D, Yamawaki T, Sugiyama E.

 A report of three cases with lupus myelitis. Eur J Rheumatol. 4: 148-150, 2017.

 

●Himeno T, Kuriyama M, Takemaru M, Kanaya Y, Shiga Y, Takeshima S, Takamatsu K, Shimoe Y, Fukushima T, Matsubara E.

Vascular risk factors and internal jugular venous flow in transient global amnesia: a study of 165 Japanese patients.　J Stroke Cerebrovasc Dis. 26: 2272-2278, 2017．

 

●Shiga Y, Kuriyama M, Kanaya Y, Takeshima S, Takemaru M, Takamatsu K, Shimoe Y, Fujikawa Y, Nishigaki M.

Serum 1,5-anhydroglucitol: risk factor of acute ischemic stroke and transient ischemic attack in well-controlled diabetes. Cerebrovasc Dis. 44: 325-329, 2017.

 

●Nishikawa Y, Watanabe K, Takahashi T, Orita N, Kimura H, Matsumoto M, Maruyama H.

Spatial electromyography distribution pattern of the vastus lateralis muscle during ramp up contractions in Parkinson's disease patients. J Electromyogr Kinesiol. 37: 125-131, 2017.

 

●Hosomi N, Nagai Y, Kitagawa K, Nakagawa Y, Aoki S, Nezu T, Kagimura T, Maruyama H, Origasa H, Minematsu K, Uchiyama S, Matsumoto M. J-STARS collaborators.

Pravastatin Reduces the Risk of Atherothrombotic Stroke when Administered within Six Months of an Initial Stroke Event. J Atheroscler Thromb. 2017, in press.

 

●Nomura E, Yamashita T, Takahashi Y, Tsunoda K, Shang J, Sato K, Takemoto M, Hishikawa N, Ohta Y, Ueno H, Abe K.

Occult chronic progressive cervical and thoracic myelopathy without evident magnetic resonance imaging lesion. Neurology and Clinical Neuroscience. 5: 155–158, 2017.

 

●Ueno H, Yamada H, Hara N, Maruyama H, Miyoshi A.

Pyrimethamine-induced transient leukoencephalopathy: Similarity to methotrexate encephalopathy. Neurology and Clinical Neuroscience. 5: 75, 2017.

 

●Miyamoto T, Akutsu SN, Fukumitsu A, Morino H, Masatsuna Y, Hosoba K, Kawakami H, Yamamoto T, Shimizu K, Ohashi H, Matsuura S.

PLK1-mediated phosphorylation of WDR62/MCPH2 ensures proper mitotic spindle orientation. Hum Mol Genet. 26(22): 4429-4440, 2017.

●Yoshida M, Ikeda J, Urikane Y, Kashiwada T, Kaseda Y, Kohriyama T.

Prevalence of tracheotomy and percutaneous endoscopic gastrostomy in patients with Guillain-Barré syndrome. Dysphagia. 32(2): 236-240, 2017.

 

 

<2016年>

英文原著

●Nezu T, Hosomi N, Kondo K, Aoki S, Matsumoto M, Kobayashi S.

Greater severity of neurological defects in women admitted with AF-related stroke. Circ J. 80: 250-255, 2016.

 

●Naito H, Naka H, Kobayashi M, Kanaya Y, Naito K, Kurashige T, Tokinobu H, Matsumoto M. Prevalences of Peripheral Arterial Disease Diagnosed by CT Angiography in Patients with Acute Ischemic Stroke. J Stroke Cerebrovasc Dis. 25: 1128-1134, 2016.

 

●Naito H, Kurashige T, Kobayashi M, Naito K, Naka H, Tokinobu H. Magnetic resonance spectroscopy after methanol poisoning. Neurology Clinical Neuroscience. 4:112-114.2016.

 

●Hosomi N, Yoshimoto T, Kanaya Y, Neshige S, Hara N, Himeno T, Kono R, Takeshima S, Takamatsu K, Ota T,Miyamoto Y, Yasuda K, Shimoe Y, Ota T, Kuriyama M, Matsumoto M.

BNP and Particular Left Ventricle Segment Asynergy Associate with Cardioembolic Stroke from Old Myocardial Infarction. J Stroke Cerebrovasc Dis. 25: 1165-1171, 2016.

 

●Nakamori M, Hosomi N, Takaki S, Oda M, Hiraoka A, Yoshikawa M, Matsushima H, Ochi K, Tsuga K, Maruyama H, Izumi Y, Matsumoto M.

Tongue thickness evaluation using ultrasonography can predict swallowing function in amyotrophic lateral sclerosis patients. Clin Neurophysiol. 127: 1669-1674, 2016.

 

●Yamada M, Landes RD, Mimori Y, Nagano Y, Sasaki H.

Radiation effects on cognitive function among atomic bomb survivors exposed at or after adolescence. Am J Med. 129: 586-591, 2016.

 

●Haruta D, Akahoshi M, Hida A, Sera N, Imaizumi M, Ichimaru S, Nakashima E, Takahashi I, Ohishi W, Fukae S, Maemura K.

Prognostic significance of premature ventricular contractions without obvious heart diseases determined by standard 12-lead electrocardiography considering their morphology. Ann Noninvasive Electrocardiol. 21: 142-151, 2016.

 

●Nakamori M, Hosomi N, Ishikawa K, Imamura E, Shishido T, Ohshita T, Yoshikawa M, Tsuga K, Wakabayashi S, Maruyama H, Matsumoto M.

Prediction of pneumonia in acute stroke patients using tongue pressure measurements. PLos One. 11: e0165837, 2016.

 

●Nishikawa Y, Hosomi N, Ueno H, Kurashige T, Ochi K, Takahashi T, Orita N, Ueda K, Maruyama H, Kimura H, Matsumoto M.

Deviation in the recovery of the lower limb and respiratory muscles of patients with polymyositis: a preliminary clinical study. J Phys Ther Sci. 28: 2652-2655, 2016.

 

●Nezu T, Hosomi N, Lip GY, Aoki S, Shimomura R, Maruyama H, Yagita Y, Matsumoto M, Kobayashi S, Japan Standard Stroke Registry Group.

Temporal Trends in stroke severity and prior antithrombotic use among acute ischemic stroke patients in Japan. Circ J. 80: 2033-2036, 2016.

 

●Naito H, Aoki S, Sumi N, Ochi K, Hosomi N, Maruyama H, Matsumoto M.

Warfarin-resistant deep vein thrombosis during the treatment of acute ischemic stroke in lung adenocarcinoma. J Stroke Cerebrovasc Dis. 25: e141-145, 2016.

 

●Sugiura T, Matsuda S, Kurosawa K, Nakai N, Fukumoto K, Takahashi T, Maruyama H, Imaizumi K, Matsumoto M, Takumi T.

Translocated in liposarcoma regulates the distribution and function of mammalian enabled, a modulator of actin dynamics. FEBS J. 283: 1475-1487, 2016.

 

●Aoki S, Hosomi N, Hirayama J, Nakamori M, Yoshikawa M, Nezu T, Kubo S, Nagano Y, Nagao A, Yamane N, Nishikawa Y, Takamoto M, Ueno H, Ochi K, Maruyama H, Yamamoto H, Matsumoto M; Hiroshima University Hospital Stroke Swallowing Team.

The multidisciplinary swallowing team approach decreases pneumonia onset in acute stroke patients. PLoS One. 11: e0154608, 2016.

 

●Toyoda K, Minematsu K, Yasaka M, Nagai Y, Hosomi N, Origasa H, Kitagawa K, Uchiyama S, Koga M, Matsumoto M; J-STARS Investigators.

The Japan Statin Treatment Against Recurrent Stroke (J-STARS) Echo Study: Rationale and Trial Protocol. J Stroke Cerebrovasc Dis. 26: 595-599, 2016.

 

●Matsushima H, Hosomi N.

"Get With the Guideline" Treatment With Statin. Circ J. 80: 603-604, 2016.

 

●Nishida N, Sueda Y, Kanbara T, Kurashige T, Torii T.

Deep cerebral vein thrombosis due to iron deficiency anemia: A case report. Case Reports in Internal Medicine. 3(3): 4-6, 2016.

 

●Sone J*, Mori K, Inagaki T, Katsumata R, Takagi S, Yokoi S, Araki K, Kato T, Nakamura T, Koike H, Takashima H, Hashiguchi A, Kohno Y, Kurashige T, Kuriyama M, Takiyama Y, Tsuchiya M, Kitagawa N, Kawamoto M, Yoshimura H, Suto Y, Nakayasu H, Uehara N, Sugiyama H, Takahashi M, Kokubun N, Konno T, Katsuno M, Tanaka F, Iwasaki Y, Yoshida M, Sobue G. Clinicopathological features of adult-onset neuronal intranuclear inclusion disease. Brain. 139: 3170-3186, 2016.

 

●Hemmi S, Kurokawa K, Nagai T, Okamoto T, Murakami T, Sunada Y. Whole plantar nerve conduction study with disposable strip electrodes. Muscle Nerve. 53: 209-213, 2016.

 

●Nagatsuka K, Miyata S, Kada A, Kawamura A, Nakagawara J, Furui E, Takiuchi S, Taomoto K, Kario K, Uchiyama S, Saito K, Nagao T, Kitagawa K, Hosomi N, Tanaka K, Kaikita K, Katayama Y, Abumiya T, Nakane H, Wada H, Hattori A, Kimura K, Isshiki T, Nishikawa M, Yamawaki T, Yonemoto N, Okada H, Ogawa H, Minematsu K, Miyata T. Cardiovascular events occur independently of high on-aspirin platelet reactivity and residual COX-1 activity in stable cardiovascular patients.Thromb Haemost. 116(2): 356-68. 2016.

 

●Kamimura T, Nomura E, Hara N, Maetani Y, Agari D, Ichimura K, Yoshida H, Yamawaki T. Carotid Artery Dissection and Ischemic Stroke Originating from Localized Aortic Arch Dissection. J Stroke Cerebrovasc Dis. 25(11): e209-e211. 2016.

 

●Ikeda J, Kaseda Y, Namba T, Ochi M, Hayata M, Kohriyama T. Inpatient Multidisciplinary Rehabilitation Intervention Outcomes for Neuromyelitis Optica Spectrum Disorder: A Retrospective Observational Study. Progress in Rehabilitation Medicine. 1: 20160007. 2016.

 

●Nezu T, Mukai T, Uemura J, Yamashita M, Kitano T, Wada Y, Yagita Y.

Multiple infarcts are associated with long-term stroke recurrence and all-cause mortality in cryptogenic stroke patients. Stroke. 47: 2209-2215, 2016

英文総説

●Nezu T, Hosomi N, Aoki S, Matsumoto M.

Carotid Intima-Media Thickness for Atherosclerosis. J Atheroscler Thromb. 23: 18-31, 2016.

 

 

<2015年>

英文原著

●Nezu T, Aoki S, Ochi K, Sugihara S, Takahashi T, Hosomi N, Maruyama H, Matsumoto M.

A case of recurrent ischemic stroke involving sub-acute, progressive intracranial cerebral arterial sclerosis prior to diagnosis with JAK2-mutated polycythemia vera. J Stroke Cerebrovasc Dis. 24: e4-6, 2015.

 

●Hosomi N, Nagai Y, Kohriyama T, Ohtsuki T, Aoki S, Nezu T, Maruyama H, Sunami N, Yokota C, Kitagawa K, Terayama Y, Takagi M, Ibayashi S, Nakamura M, Origasa H, Fukushima M, Mori E, Minematsu K, Uchiyama S, Shinohara Y, Yamaguchi T, Matsumoto M. for the J-STARS collaborators.

The Japan Statin Treatment against Recurrent Stroke (J-STARS): a multicenter, randomized, open-label, parallel-group study. EBioMedicine. 2: 1071-1078, 2015.

 

●Aoki S, Hosomi N, Sueda Y, Kono T, Takamatsu K, Ohyama H, Torii T, Kitamura T, Nomura E, Noda K, Ohtsuki T, Matsumoto M, and the HARP Registry Study Group. Multicenter study of intravenous recombinant tissue plasminogen activator infusion around Hiroshima, Japan –HARP Registry Study– J Stroke Cerebrovasc Dis. 24: 2747-2753, 2015.

 

●Nishikawa Y, Aizawa J, Kanemura N, Takahashi T, Hosomi N, Maruyama H, Kimura H, Matsumoto M, Takayanagi K.

 Immediate effects passive and active stretching on hamstrings flexibility: a single-blinded randomized control trial. J Phys Ther Sci. 27: 3167-3170, 2015.

 

●Nezu T, Hosomi N, Takahashi T, Anno K, Aoki S, Shimamoto A, Maruyama H, Hayashi T, Matsumoto M, Tahara H.

Telomere G-tail length is a promising biomarker related to white matter lesions and endothelial dysfunction in patients with cardiovascular risk: a cross-sectional study. EBioMedicine. 2: 960–967, 2015.

 

●Sueda Y, Hosomi N, Tsunematsu M, Takamatsu K, Nomura E, Torii T, Ohtsuki T, Aoki S, Mukai T, Nezu T, Kakehashi M, Matsumoto M; HEWS-tPA collaborators. Effects of Meteorological Conditions on the Risk of Ischemic Stroke Events in Patients Treated with Alteplase-HEWS-tPA. J Stroke Cerebrovasc Dis. 24: 1500-1505, 2015.

 

●Llombart V, Antolin-Fontes A, Bustamante A, Giralt D, Rost NS, Furie K, Shibazaki K, Biteker M, Castillo J, Rodríguez-Yáñez M, Fonseca AC, Watanabe T, Purroy F, Zhixin W, Etgen T, Hosomi N, Kerman SRJ, Sharma JC, Knauer C, Santamarina E, Giannakoulas G, García-Berrocoso T, Montaner J.

B-type natriuretic peptides help in cardioembolic stroke diagnosis: a pooled data meta-analysis. Stroke. 46: 1187-1195, 2015.

 

●Nezu T, Hosomi N, Aoki S, Kubo S, Araki M, Mukai T, Takahashi T, Maruyama H, Higashi Y, Matsumoto M.

Endothelial dysfunction is associated with the severity of cerebral small vessel disease. Hypertens Res. 38: 291-297, 2015.

 

●Nomura, E, Ohshita T, Imamura E, Wakabayashi S, Kajikawa H, Hosomi N, Matsumoto M.

Early administration of non-vitamin K antagonist oral anticoagulants for acute ischemic stroke with atrial fibrillation in comparison to warfarin mostly combined with heparin. Circ J. 79: 862–866, 2015.

 

●Fukuoka Y, Hosomi N, Hyakuta T, Omori T, Ito Y, Uemura J, Kimura K, Matsumoto M, Moriyama M; DMP Stroke Trial Investigators. Baseline feature of a randomized trial assessing the effects of disease management programs for the prevention of recurrent ischemic stroke. J Stroke Cerebrovasc Dis. 24: 610-617, 2015.

 

●Sugimoto T, Hosomi N, Nezu T, Takahashi T, Aoki S, Takeda I, Mukai T, Ochi K, Kitamura T, Ohtsuki T, Matsumoto M.

CD34+/CD144+ Circulating Endothelial Cells as an Indicator of Carotid Atherosclerosis. J Stroke Cerebrovasc Dis. 24: 583-590, 2015.

 

●Nomura E, Suzuki A, Inoue I, Nakagawara J, Takahashi K, Takahashi T, Manabe Y, Yokota C, Okada K, Nishihara T, Yamamoto Y, Noda K, Takahashi S, Ibayashi S, Takagi M, Kitagawa K, Tanahashi N, Kuriyama M, Hirata K, Hosomi N, Minematsu K, Kobayashi S, Matsumoto M, J-STARS-L Investigators.

Subsequent vascular events after ischemic stroke: the Japan Statin Treatment Against Recurrent Stroke-Longitudinal (J-STARS-L). J Stroke Cerebrovasc Dis. 24: 473-479, 2015.

 

●Fujii K, Moriwaki K, Torii T, Hashimoto K, Shiroyama K, Tajima M, Sanuki M, Kurita S.

Urinary retention occurring one week after spinal anesthesia: a case of Elsberg syndrome. Can J Anaesth. 62: 50-53, 2015.

 

●Kim HJ, Nagano Y, Choi SJ, Park SY, Kim H, Yao TP, Lee JY.

HDAC6 maintains mitochondrial connectivity under hypoxic stress by suppressing MARCH5/MITOL dependent MFN2 degradation. Biochem Biophys Res Commun. 464: 1235-1240, 2015.

 

●Yamada M, Landes RD, Mimori Y, Nagano Y, Sasaki H.

Trajectories of cognitive function in dementia-free subjects: Radiation Effects Research Foundation Adult Health Study. J Neurol Sci. 351: 115-119. 2015.

 

●Ohshita T, Imamura E, Nomura E, Wakabayashi S, Kajikawa H, Matsumoto M.

Hypoglycemia with focal neurological signs as stroke mimic: Clinical and neuroradiological characteristics. J Neurol Sci. 353: 98-101, 2015.

 

●Ishihara Kawase K, Kokubo Y, Yokota C, Hida E, Miyata T, Toyoda K, Matsumoto M, Minematsu K, Miyamoto Y.

Effect of Plasma Fibrinogen, High-Sensitive C-Reactive Protein, and Cigarette Smoking on Carotid Atherosclerosis: The Suita Study. J Stroke Cerebrovasc Dis. 24: 2385-2389, 2015.

 

●Imaizumi M, Ohishi W, Nakashima E, Sera N, Neriishi K, Yamada M, Tatsukawa Y, Takahashi I, Fujiwara S, Sugino K, Ando T, Usa T, Kawakami A, Akahoshi M, Hida A.

Association of radiation dose with prevalence of thyroid nodules among atomic bomb survivors exposed in childhood (2007-2011). JAMA Intern Med. 175: 228-236, 2015.

 

●Itakura K, Takahashi I, Nakashima E, Yanagi M, Kawasaki R, Neriishi K, Wang JJ, Wong TY, Hida A, Ohishi W, Kiuchi Y.

Exposure to atomic bomb radiation and age-related macular degeneration in later life: the Hiroshima-Nagasaki atomic bomb survivor study. Invest Ophth Vis Sci. 56: 5401-5406, 2015.

 

●Grant EJ, Furukawa K, Sakata R, Sugiyama H, Sadakane A, Takahashi I, Utada M, Shimizu Y, Ozasa K. Risk of death among the children of the atomic bomb survivors, an update after 62 years of follow-up: a cohort study. Lancet Oncol. 16: 1316-1323, 2015.

 

●Neshige S, Kuriyama M, Yoshimoto T, Takeshima S, Himeno T, Takamatsu K, Sato M, Ota S. Seizures after intracerebral hemorrhage; risk factor, recurrence, efficacy of antiepileptic drug. J Neurol Sci. 359: 318-322, 2015.

 

●Hama Y, Uehara T, Ohara T, Kimura K, Okada Y, Hasegawa Y, Tanahashi N, Suzuki A, Takagi S, Nakagawara J, Arii K, Nagahiro S, Ogasawara K, Nagao T, Uchiyama S, Matsumoto M, Iihara K, Toyoda K, Minematsu K. Clinical Characteristics of Transient Ischemic Attack Patients with Atrial Fibrillation: Analyses of a Multicenter Retrospective Study. Cerebrovasc Dis Extra. 5: 84-90, 2015.

 

●Zhang L, Zhang S, Maezawa I, Trushin S, Minhas P, Pinto M, Jin LW, Prasain K, Nguyen TD, Yamazaki Y, Kanekiyo T, Bu G, Gateno B, Chang KO, Nath KA, Nemutlu E, Dzeja P, Pang YP, Hua DH, Trushina E. Modulation of mitochondrial complex I activity averts cognitive decline in multiple animal models of familial Alzheimer's Disease. EBioMedicine. 2: 294-305, 2015.

 

●Casey CS, Atagi Y, Yamazaki Y, Shinohara M, Tachibana M, Fu Y, Bu G, Kanekiyo T. Apolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway. J Biol Chem. 290: 14208-14217, 2015.

 

●Muir RT, Lam B, Honjo K, Harry RD, McNeely AA, Gao FQ, Ramirez J, Scott CJM, Ganda A, Zhao J, Zhou XJ, Graham SJ, Rangwala N, Gibson E, Lobaugh NJ, Kiss A, Stuss DT, Nyenhuis DL, Lee BC, Kang Y, Black SE. Trail making test elucidates neural substrates of specific poststroke executive dysfunctions. Stroke. 46: 2755-2761, 2015.

 

●Shingo AS, Mervis RF, Kanabayashi T, Kito S, Murase T.

The dendrites of granule cell layer neurons are the primary injury sites in the “Brain Diabetes” rat. Behav Brain Res. 280: 78-83, 2015.

 

●Nishikawa T, Takahashi T, Nakamori M, Hosomi N, Maruyama H, Miyazaki Y, Izumi Y, Matsumoto M.

The identification of raft-derived tau-associated vesicles that are incorporated into immature tangles and paired helical filaments. Neuropathol Appl Neurobiol. 27: 3167-3170, 2015.

 

●Morino H, Matsuda Y, Muguruma K, Miyamoto R, Ohsawa R, Ohtake T, Otobe R, Watanabe M, Maruyama H, Hashimoto K, Kawakami H.

A mutation in the low voltage-gated calcium channel CACNA1G alters the physiological properties of the channel, causing spinocerebellar ataxia. Mol Brain. 8: 89, 2015.

 

 

<2014年>

英文原著

●Kano O, Yoshioka M, Nagayama H, Hamada S, Maeda T, Hasegawa T, Kadowaki T, Sengoku R, Terashi H, Hatano T, Nomoto N, Inoue M, Shimura H, Takahashi T, Uchiyama T, Watanabe H, Kaneko S, Takahashi T, Baba Y, Kubo S.
Rhinorrhea in Parkinson's disease: a consecutive multicenter study in Japan. J Neurol Sci. Aug 15; 343(1-2): 88-90, 2014.

 

●Nishikawa T, Takahashi T, Nakamori M, Yamazaki Y, Kurashige T, Nagano Y, Nishida Y, Izumi Y, Matsumoto M.
Phosphatidylinositol-4,5-bisphosphate is enriched in granulovacuolar degeneration bodies and neurofibrillary tangles. Neuropathol Appl Neurobiol. 40(4): 489-501, 2014.

 

●Fujii H, Nagano Y, Hosomi N, Matsumoto M.
Dural arteriovenous fistula presenting with progressive dementia and parkinsonism. BMJ Case Rep. bcr2014203921, 2014.

 

●Ueno H, Tomimura H, Yoshimoto T, Ochi K, Nomura E, Maruyama H, Matsumoto M.
Paroxysmal dysarthria and ataxia in chronic lymphocytic inflammation with pontine perivascular enhancemet responsive to steroids. Neurology and Clinical Neuroscirnce. Jan/Mar/no.1/2 vol.2.doi:10.1111/ncn3.69, 2014.

 

●Takeda I, Takahashi T, Ochi K, Kurashige T, Shinozaki Y, Nakamori M, Arihiro K, Maruyama H, Matsumoto M.
Fiber Type-Specific Expression of Low-Density Lipoprotein Receptor-Related Protein 6 in Human Skeletal Muscles. Pathobiology. 81: 94-99, 2014.

 

●Fujii H, Ohtsuki T, Takeda I, Hosomi N, Matsumoto M.
Isolated unilateral hypoglossal nerve paralysis caused by internal carotid artery dissection. J Stroke Cerebrovasc Dis. 23(8): e405-e406, 2014.

 

 

<2013年>

英文原著

●Kurashige T, Takahashi T, Yamazaki Y, Nagano Y, Kondo K, Nakamura T, Yamawaki T, Tsuburaya R, Hayashi YK, Nonaka I, Nishino I, Matsumoto M.
Elevated urinary β2 microglobulin in the first identified Japanese family afflicted by X-linked myopathy with excessive autophagy. Neuromuscul Disord. 23(11): 911-916, 2013

 

●Sugimoto T, Hosomi N, Milai T, Ueno H, Nakamura T, Takahashi T, Ohtsuki T, Yamawaki T, Kohriyama T, Matsumoto M.
The effect of physical characteristics on reference nerve sizes at multiple/levels of the arm and neck. Stroke. Cerebrovascular Diseases. (35) suppl2: 30, 2013.

 

●Mukai T, Hosomi N, Segawa A, Kinoshita N, Kitamura J, Aoki S, Ueno H, Ochi K, Yamawaki T, Matsumoto M.
Bilateral internal carotid artery dissection in Behcet's disease patient; a case report. Stroke. Cerebrovascular Diseases. (35) uppl2: 51, 2013.  

 

●Sugimoto T, Ochi,K,Hosomi,N, Mukai T, Ueno H, Takahashi T, Ohtsuki T, Kohriyama T, Masayasu M.
Ultrasonographic reference sizes of the median and ulnar nerves and the cervical nerve roots in healthy Japanese adults. Ultrasound Med Biol. 39(9): 1560-70, 2013.

 

●Takeda I, Takahashi T, Ueno H, Morino H, Ochi K, Nakamura T, Hosomi N, Kawakami H, Hashimoto K, Matsumoto M.
Autosomal recessive Andersen-Tawil syndrome with a novel mutation L94P in Kir2.1. Neurolory and Clinical Neuroscience. (1): 131-137, 2013

 

●Nezu T, Hosomi N, Aoki S, Deguchi K, Masugata H, Ichihara N, Ohyama H, Ohtsuki T, Kohno M, Matsumoto M.
Alpha2-macroglobulin as a promising biomarker for cerebral small vessel disease in acute ischemic stroke patients. J Neurol. 260: 2642-2649, 2013.

 

●Nakamori M, Takahashi T, Nishikawa T, Yamazaki Y, Kurashige T, Maruyama H, Arihiro K, Masayasu M.
Molecular Markers for Granulovacuolar Degeneration Are Present in Rimmed Vacuoles. PLOS ONE. 8(11): e80995, 2013.

 

●Umemoto S, Ogihara T, Rakugi H, Matsumoto M, Kitagawa K, Shimada K, Higaki J, Ito S, Suzuki H, Ohashi Y, Saruta T, Matsuzaki M.
Effects of a benidipine-based combination therapy on the risk of stroke according to stroke subtype: the COPE trial. Hypertens Res. 36(12): 1088-95, 2013.

 

●Hosomi N, Nishiyama A, Matsumoto M.
Do RAS inhibitors protect the brain from cerebral ischemic injury? Curr Hypertens Rev. 9(2): 86-92, 2013.

 

●Sugimoto T, Ochi K, Hosomi N, Takahashi T, Ueno H, Nakamura T, Nagano Y, Maruyama H, Kohriyama T, Matsumoto M.
Ultrasonographic nerve enlargement of the median and ulnar nerves and the cervical nerve roots in patients with demyelinating Charcot-Marie-Tooth disease: distinction from patients with chronic inflammatory demyelinating polyneuropathy. J Neurol. 260: 2580-2587, 2013.

 

●Ogawa A, Yamazaki Y, Nakamori M, Takahashi T, Kurashige T, Hiji M, Nagano Y, Yamawaki T, Matsumoto M.
Characterization and distribution of adaptor protein containing a PH domain, PTB domain and leucine zipper motif (APPL1) in Alzheimer's disease hippocampus: an immunohistochemical study. Brain Res. 4: 1494: 118-24, 2013.

 

●Masugata H, Senda S, Inukai M, Himoro T, Imachi H, Murao K, Hosomi N, Okada H, Goda F.
Association between oxidative stress assessed by urinary 8-hydroxydeoxyguanosine and the cardiac function in hypertensive patients without overt heart disease. Clin Exp Hypertens. 35(5):308-12, 2013.

 

 

<2012年>

英文原著

●Nagayama H, Kubo S, Hatano T, Hamada S, Maeda T, Hasegawa T, Kadowaki T, Terashi H, Yoshioka M, Nomoto N, Kano O, Inoue M, Shimura H, Takahashi T, Uchiyama T, Watanabe H, Kaneko S, Takahashi T, Baba Y.
Validity and reliability assessment of a Japanese version of the Snaith-Hamilton pleasure scale. Intern Med. 51(8): 865-9, 2012.

 

●Ueno H, Matsumoto M.
Neuropharmacokinetic heterogeneity of mefloquine in the treatment of progressive multifocal leukoencephalopathy. Intern Med. 51(16): 2259, 2012.

 

●Hosomi N, Aoki S, Matsuo K, Deguchi K, Masugata H, Murao K, Ichihara N, Ohyama H, Dobashi, Nezu T, Ohtsuki T, Yasuda O, Soejima H, Ogawa H, Izumi Y, Kohno M, Tanaka J, Matsumoto M
Association of Serum Anti-Periodontal Pathogen Antibody with Ischemic Stroke. Cerebrovascular Dis. 34(5-6): 385-392, 2012.

 

●Suzuki N, Sato M, Houkin K, Terayama Y, Uchiyama S, Daida H, Shigematsu H, Goto S, Tanaka K, Origasa H, Miyamoto S, Minematsu K, Matsumoto M, Okada Y.
One-year Atherothrombotic Vascular Events Rates in Outpatients with Recent Non-cardioembolic Ischemic Stroke:The EVEREST(Effective Vascular Event Reduction after Stroke)Registry. Journal of Stroke and Cerebrovascular Dis. 21(4): 245-253, 2012.

 

●Kurashige T, Takahashi T, Yamazaki Y, Hiji M, Yamawaki T, Matsumoto M.
Localization of CHMP2B-immunoreactivity in the brainstem of Lewy body disease. Neuropathology. 33(3): 237-45, 2012.

 

●Nakamori M, Takahashi T, Yamazaki Y, Kurashige T, Yamawaki T, Matsumoto M.
Cyclin-dependent kinase 5 immunoreactivity for granulovacuolar degeneration. Neuroreport. 23(15): 867-872, 2012.

 

●Hosomi N, Sueda Y, Masugata H, Dobashi H, Murao K, Ueno M, Miki T, Kohno M, Nishiyama A, Matsumoto M.
The optimal timing of antihypertensive medication administration for morning hypertension in patients with cerebral infarction. Hypertens Res. 35(7): 720-724, 2012.

 

●Nomura E, Naka H, Wakabayashi S, Kajikawa H, Matsumoto M
Leukocytes May Have 2 Opposing Effects in Intravenous rtPA Treatment for Ischemic Stroke. Clin Appl Thromb Hemost. 20(1): 37-42, 2012.

 

●Sumi S, Origasa H, Houkin K, Terayama Y, Uchiyama S, Daida H, Shigematsu H, GAoto S, Tanaka K, Miyamoto S, Minematsu K, Matsumoto M, Okada Y, Sato M, Suzuki N.
A modified Essen stroke risk score for predicting recurrent cardiovascular events: development and validation. Int J Stroke: 1747-4949, 2012.

 

●Sugihara K, Maruyama H, Morino H, Miyamoto R, Ueno H, Matsumoto M, Kaji R, Kitaguchi H, Yukitake M, Higashi Y, Nishikawa K, Oda M, Izumi Y, Kawakami H.
The clinical characteristics of spinocerebellar ataxia 36: a study of 2121 Japanese ataxia patients. Mov Disord. 27(9): 1158-1163, 2012.

 

●Hori M, Matsumoto M, Tanahashi N, Momomura S, Uchiyama S, Goto S, Izumi T, Koretsune, Kajimawa M, Kato M, Iwamoto K, Tajiri M, J-ROCKET AF Study.

Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation - the J-ROCKET AF study -. investigators. Circ J. 76(9): 2104-2111, 2012.

 

●Dohi E, Tanaka S, Seki T, Miyagi T, Takahashi T, Matsumoto M, Sakai N.
Hypoxic stress activates chaperone-mediated autophagy and modulates neuronal cell survival. Neurochem Int. 60(4): 431-442, 2012.

 

●Nezu T, Yokota C, Uehara T, Yamauchi M, Fukushima K, Toyoda K, Matsumoto M, Iida H, Minematsu K.
Preserved acetazolamide reactivity in lacunar patients with severe white-matter lesions: 15O-labeled gas and H2O positron emission tomography studies. J Cereb Blood Flow Metab. 32(5): 844-850, 2012.

 

●Nezu T, Arihiro S, Toyoda K, Minematsu K.
Small-Vessel Disease in the Basal Ganglia: Lacune or Microbleed? J Stroke Cerebrovasc Dis. 21(8): 905, 2012.

 

●Naito K, Ueno H, Sekine M, Kanemitsu M, Ohshita T, Nakamura T, Yamawaki T, Matsumoto M.
Akinetic mutism caused by HIV-associated progressive multifocal leukoencephalopathy was successfully treated with mefloquine: a serial multimodal MRI Study. Intern Med. 51(2): 205-209, 2012.

 

●Kono T, Ohtsuki T, Hosomi N, Takeda I, Aoki S, Sueda Y, Ishihara K, Nakamura T, Yamawaki T, Matsumoto M.
Cancer-associated ischemic stroke is associated with elevated D-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancer. Geriatr Gerontol Int. 12(3): 468-574, 2012.

 

●Tanitame K, Iwakado Y, Akiyama Y, Ueno H, Ochi K, Otani K, Takasu M, Date S, Awai K.
Effect of age on the fractional anisotropy (FA) value of peripheral nerves and clinical significance of the age-corrected FA value for evaluating polyneuropathies. Neuroradiology. 54(8): 815-821, 2012.

 

●Naka H, Nomura E, Kitajima J, Imamura E, Wakabayashi S, Matsumoto M.
Antiplatelet Therapy as a Risk Factor for Microbleeds in Intracerebral Hemorrhage Patients: Analysis Using Specific Antiplatelet Agents. J Stroke Cerebrovasc Dis. 22(6): 834-40, 2012.